---
title: "BioNTech SE sponsored ADR SE (BNTX.US) Q1 2022 Earnings Conference Call."
description: "BioNTech SE Sponsored ADRSE is dedicated to the development of new drugs in the cross-field of immunology and synthetic biology. Its product line includes BNT16"
locale: "en"
url: "https://longbridge.com/en/lives/11958"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# BioNTech SE sponsored ADR SE (BNTX.US) Q1 2022 Earnings Conference Call.

**Status**: Unknown
**Category**: Earnings Call

## Description

BioNTech SE Sponsored ADRSE is dedicated to the development of new drugs in the cross-field of immunology and synthetic biology. Its product line includes BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T cells, TCR, and next-generation CP immune modulators. The company was founded by Christopher Huber, Ozlem Tureci, and Ugur Sahin on June 2, 2008, and is headquartered in Mainz, Germany.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.